Products

Human ABL1(Tyrosine-protein kinase ABL1) ELISA Kit
One-click to copy product information
ELK9828
Size： Price：
48 T $320.00
96 T $458.00
96 T*5 $1947.00
Manual MSDS Send email to us

Overview

Product name: Human ABL1(Tyrosine-protein kinase ABL1) ELISA Kit
Reactivity: Human
Alternative Names: ABL1; ABL; JTK7; Tyrosine-protein kinase ABL1; Abelson murine leukemia viral oncogene homolog 1; Abelson tyrosine-protein kinase 1; Proto-oncogene c-Abl; p150
Assay Type: Sandwich
Sensitivity: 17 pg/mL
Standard: 4000 pg/mL
Detection Range: 62.5-4000 pg/mL
Sample Type: serum, plasma, tissue homogenates
Assay Length: 3.5h
Research Area: Signal Transduction; Cancer; Epigenetics and Nuclear Signaling; Neuroscience
Uniprot ID: P00519
Test principle: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human ABL1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human ABL1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human ABL1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human ABL1 in the samples is then determined by comparing the OD of the samples to the standard curve.

Standard curve

Concentration (pg/mL) OD Corrected OD
4000.00 2.131 2.049
2000.00 1.527 1.445
1000.00 1.282 1.200
500.00 0.828 0.746
250.00 0.527 0.445
125.00 0.321 0.239
62.50 0.203 0.121
0.00 0.082 0.000

Precision

Intra-assay Precision (Precision within an assay)：CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays)：CV%<10%

Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.

Recovery

Matrices listed below were spiked with certain level of recombinant ABL1 and the recovery rates were calculated by comparing the measured value to the expected amount of ABL1 in samples.
Matrix Recovery range Average
serum(n=5) 90-105% 97%
EDTA plasma(n=5) 79-93% 86%
Heparin plasma(n=5) 80-95% 87%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of ABL1 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Matrix 1:2 1:4 1:8 1:16
serum(n=5) 95-106% 85-101% 87-102% 84-98%
EDTA plasma(n=5) 83-96% 93-102% 95-103% 93-102%
Heparin plasma(n=5) 92-101% 88-102% 87-102% 93-102%